Latest Polypill Stories
NEW YORK, October 5, 2010 /PRNewswire/ -- - New Research Which Shows That Timing Blood Pressure Medication With a Patient's Body Clock Make it More Effective and Offers Greater Protection Against the Occurrence of Heart Attacks and Strokes is Set to Change the Hypertension Treatment for Hundreds of Millions of People Worldwide Chronobiology International - the international journal on how biological rhythms affect the systems of living things - has published the results of a...
An intensive lifestyle intervention program designed to achieve and maintain weight loss improves diabetes control and cardiovascular disease risk factors in overweight and obese individuals with type 2 diabetes.
Experts are now recommending that low-dose aspirin therapy to prevent heart attacks be used somewhat more conservatively â€“ that men younger than 50 and women younger than 60, who have diabetes but no other major risk factors, probably not use aspirin.
Researchers at the University of Warwick have identified a particular combination of health problems that can double the risk of heart attack and cause a three-fold increase in the risk of mortality.
WILMINGTON, N.C., Oct. 8 /PRNewswire/ -- CardioPharma is beginning the final funding phase before submitting an NDA for CardiaPill, the world's first patented triple-combination cardiovascular polypill.
Many people are not receiving the best possible care when it comes to managing cardiovascular conditions according to two new Australian research studies.
A five-in-one pill that may cut a person's risk of cardiovascular disease by 50 to 60 percent was well-tolerated by participants in the first study to evaluate the pill in humans.
A major study has found promising new results for an experimental pill that could serve as a one-size-fits-most treatment to prevent heart attacks and stroke.
Lowering blood pressure protects dialysis patients from major cardiovascular events and death, researchers in Australia said. The study, published in The Lancet, also said that treatment with blood-pressure lowering drugs should be routinely considered for patients undergoing dialysis.
- A person or thing gazed at with wonder or curiosity, especially of a scornful kind.